Table: Phoenixbio - 6-MTH group results

PhoenixBio

14/11/2022 06:30

Nov 14 (Reuters)- 
             Phoenixbio Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Sep 30, 2022        Sep 30, 2021     Mar 31, 2023 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               1.14               637 mln           1.75     
                   (+78.0 pct)                          (+32.2 pct) 
  Operating          367 mln          loss 133 mln        206 mln   
  Recurring          403 mln          loss 128 mln        211 mln   
  Net                356 mln          loss 130 mln        198 mln   
  EPS              107.65 yen        loss 39.59 yen      60.08 yen  
  EPS Diluted       71.56 yen                                       
  Ann Div                                  NIL              NIL     
  -Q2 div              NIL                 NIL                      
  -Q4 div                                  NIL              NIL     
  
  NOTE - Phoenixbio Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T